Have your own idea? Try our Stock Screener
Chinese (SSE) Healthcare Sector Analysis
UpdatedJan 12, 2026
DataAggregated Company Financials
Companies471
- 7D7.6%
- 3M0.1%
- 1Y26.7%
- YTD3.8%
In the last week, the Healthcare industry is up 7.6%, with WuXi AppTec leading the way, up 4.3%. Meanwhile, Hebei Changshan Biochemical Pharmaceutical actually underperformed within the industry, shrinking 6.0% in the last week. In the last 12 months, the industry was up 27%. Looking forward, earnings are forecast to grow by 27% annually.
Sector Valuation and Performance
Has the Chinese Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 13 Jan 2026 | CN¥6.8t | CN¥2.3t | CN¥145.1b | 41.1x | 46.6x | 3x |
| Thu, 11 Dec 2025 | CN¥6.5t | CN¥2.3t | CN¥145.1b | 38.4x | 44.6x | 2.8x |
| Sat, 08 Nov 2025 | CN¥6.6t | CN¥2.3t | CN¥143.7b | 40.5x | 46.2x | 2.9x |
| Mon, 06 Oct 2025 | CN¥6.9t | CN¥2.3t | CN¥146.9b | 39.7x | 46.7x | 3x |
| Wed, 03 Sep 2025 | CN¥7.0t | CN¥2.2t | CN¥143.8b | 41.1x | 49x | 3.2x |
| Fri, 01 Aug 2025 | CN¥6.7t | CN¥2.2t | CN¥152.8b | 39.9x | 44.1x | 3.1x |
| Sun, 29 Jun 2025 | CN¥5.9t | CN¥2.2t | CN¥150.0b | 35.4x | 39.4x | 2.7x |
| Tue, 27 May 2025 | CN¥5.8t | CN¥2.2t | CN¥150.6b | 34.5x | 38.3x | 2.6x |
| Thu, 24 Apr 2025 | CN¥5.6t | CN¥2.2t | CN¥149.2b | 33.1x | 37.5x | 2.5x |
| Sat, 22 Mar 2025 | CN¥5.7t | CN¥2.2t | CN¥154.3b | 32.8x | 36.9x | 2.5x |
| Mon, 17 Feb 2025 | CN¥5.7t | CN¥2.2t | CN¥153.8b | 32.5x | 36.9x | 2.5x |
| Wed, 15 Jan 2025 | CN¥5.4t | CN¥2.2t | CN¥154.4b | 30.1x | 34.9x | 2.4x |
| Fri, 13 Dec 2024 | CN¥6.1t | CN¥2.2t | CN¥153.7b | 35.6x | 39.4x | 2.7x |
| Sun, 10 Nov 2024 | CN¥6.1t | CN¥2.2t | CN¥154.1b | 34.4x | 39.6x | 2.7x |
| Tue, 08 Oct 2024 | CN¥6.1t | CN¥2.2t | CN¥161.8b | 35.2x | 37.5x | 2.7x |
| Thu, 05 Sep 2024 | CN¥4.9t | CN¥2.2t | CN¥162.1b | 27.3x | 30.4x | 2.2x |
| Sat, 03 Aug 2024 | CN¥5.2t | CN¥2.3t | CN¥166.1b | 28.4x | 31x | 2.3x |
| Mon, 01 Jul 2024 | CN¥5.2t | CN¥2.3t | CN¥165.0b | 28.5x | 31.2x | 2.3x |
| Wed, 29 May 2024 | CN¥5.7t | CN¥2.3t | CN¥167.8b | 30.2x | 34x | 2.5x |
| Fri, 26 Apr 2024 | CN¥5.7t | CN¥2.3t | CN¥174.5b | 29.9x | 32.5x | 2.5x |
| Sun, 24 Mar 2024 | CN¥5.9t | CN¥2.3t | CN¥179.8b | 30.9x | 32.8x | 2.6x |
| Tue, 20 Feb 2024 | CN¥5.7t | CN¥2.3t | CN¥179.8b | 28.1x | 31.5x | 2.5x |
| Thu, 18 Jan 2024 | CN¥6.0t | CN¥2.3t | CN¥176.9b | 31.8x | 33.8x | 2.6x |
| Sat, 16 Dec 2023 | CN¥6.5t | CN¥2.3t | CN¥177.1b | 34.8x | 36.7x | 2.8x |
| Mon, 13 Nov 2023 | CN¥6.6t | CN¥2.3t | CN¥177.2b | 35.7x | 37.4x | 2.9x |
| Wed, 11 Oct 2023 | CN¥6.4t | CN¥2.3t | CN¥185.2b | 32.1x | 34.3x | 2.8x |
| Fri, 08 Sep 2023 | CN¥6.0t | CN¥2.3t | CN¥186.5b | 31x | 32.3x | 2.6x |
| Sun, 06 Aug 2023 | CN¥6.5t | CN¥2.3t | CN¥193.0b | 32.5x | 33.5x | 2.8x |
| Tue, 04 Jul 2023 | CN¥6.6t | CN¥2.3t | CN¥191.9b | 34.1x | 34.4x | 2.9x |
| Thu, 01 Jun 2023 | CN¥6.9t | CN¥2.3t | CN¥191.3b | 36.1x | 36x | 3x |
| Sat, 29 Apr 2023 | CN¥7.1t | CN¥2.3t | CN¥227.7b | 37x | 31.1x | 3.1x |
| Mon, 27 Mar 2023 | CN¥7.0t | CN¥2.2t | CN¥234.6b | 36.2x | 29.7x | 3.1x |
| Wed, 22 Feb 2023 | CN¥7.4t | CN¥2.2t | CN¥233.2b | 38.8x | 31.6x | 3.3x |
| Fri, 20 Jan 2023 | CN¥7.4t | CN¥2.2t | CN¥233.4b | 38.1x | 31.9x | 3.4x |
Price to Earnings Ratio
31.9x
Current Industry PE
- Investors are optimistic on the Chinese Healthcare industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 46.6x which is higher than its 3-year average PE of 36.3x.
- The industry is trading close to its 3-year average PS ratio of 2.7x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have declined 15% per year over the last three years.
- Meanwhile revenues have remained mostly flat.
- This means that although sales have remained flat, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Trends
Which industries have driven the changes within the Chinese Healthcare sector?
| CN Market | 5.17% | |
| Healthcare | 7.62% | |
| Healthtech | 16.68% | |
| Life Sciences | 12.65% | |
| Biotech | 8.84% | |
| Medical Equipment | 8.72% | |
| Healthcare Services | 6.79% | |
| Pharma | 5.90% | |
Industry PE
- Investors are most optimistic about the Biotech industry which is trading above its 3-year average PE ratio of 80.0x.
- Analysts are expecting annual earnings growth of 42.1%, which is higher than its past year's earnings decline of 8.2% per year.
Forecasted Growth
- Analysts are most optimistic on the Healthtech industry, expecting annual earnings growth of 88% over the next 5 years.
- This is roughly in line with its past earnings growth rate.
- In contrast, the Life Sciences industry is expected to see its earnings grow by 23% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 603259 WuXi AppTec | CN¥98.68 | 4.3% +CN¥12.2b | 85.6% | PE18x | |
| 300760 Shenzhen Mindray Bio-Medical Electronics | CN¥208.03 | 4.2% +CN¥10.2b | -10.1% | PE29.2x | |
| 688506 Sichuan Biokin PharmaceuticalLtd | CN¥344.00 | 6.2% +CN¥8.3b | 83.9% | PS63.8x | |
| 300253 Winning Health Technology Group | CN¥12.97 | 40.1% +CN¥8.2b | 108.5% | PS13.2x | |
| 688271 Shanghai United Imaging Healthcare | CN¥141.68 | 6.7% +CN¥7.3b | 14.6% | PE67.9x |